Byrtus H, Pawłowski M, Charakchieva-Minol S, Duszyńska B, Mokrosz M J, Mokrosz J L, Zejc A
Department of Pharmaceutical Chemistry, Collegium Medicum, Jagiellonian University, Kraków, Poland.
Arch Pharm (Weinheim). 1996 Jun;329(6):283-90. doi: 10.1002/ardp.19963290604.
A series of new 3-(omega-aminoalkyl)-5,5-disubstituted hydantoins, containing 1-phenylpiperazine, 1-(o-methoxyphenyl)piperazine or 1,2,3,4-tetrahydroisoquinoline fragments, were synthesized by standard alkylation procedures and their 5-HT1A and 5-HT2A receptor affinities were determined. It has been shown that the investigated derivatives are recognized by 5-HT1A and 5-HT2A receptors due to the presence of a 1-arylpiperazine fragment however, the terminal hydantoin moiety plays an important role in stabilization of the receptor-ligand complex. It has also been found that the two 1-phenylpiperazine derivatives 32 and 36 are new selective 5-HT2A receptor ligands (Ki = 34 and 37 nM, respectively), whereas the derivative of 1-(o-methoxyphenyl)piperazine (38) is a new, highly potent 5-HT1A receptor ligand (Ki = 0.51 nM) with a moderate affinity for 5-HT2A receptors (Ki = 213 nM).
通过标准烷基化程序合成了一系列含有1-苯基哌嗪、1-(邻甲氧基苯基)哌嗪或1,2,3,4-四氢异喹啉片段的新型3-(ω-氨基烷基)-5,5-二取代乙内酰脲,并测定了它们对5-HT1A和5-HT2A受体的亲和力。结果表明,由于存在1-芳基哌嗪片段,所研究的衍生物可被5-HT1A和5-HT2A受体识别,然而,末端乙内酰脲部分在受体-配体复合物的稳定中起重要作用。还发现两种1-苯基哌嗪衍生物32和36是新型选择性5-HT2A受体配体(Ki分别为34和37 nM),而1-(邻甲氧基苯基)哌嗪衍生物(38)是新型高效5-HT1A受体配体(Ki = 0.51 nM),对5-HT2A受体具有中等亲和力(Ki = 213 nM)。